BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: State M, Negreanu L, Voiosu T, Voiosu A, Balanescu P, Mateescu RB. Surrogate markers of mucosal healing in inflammatory bowel disease: A systematic review. World J Gastroenterol 2021; 27(16): 1828-1840 [PMID: 33967560 DOI: 10.3748/wjg.v27.i16.1828] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Sakurai T, Saruta M. Positioning and Usefulness of Biomarkers in Inflammatory Bowel Disease. Digestion 2023;104:30-41. [PMID: 36404714 DOI: 10.1159/000527846] [Reference Citation Analysis]
2 Polari L, Tenhami M, Anttila S, Helenius T, Kujari H, Kallajoki M, Voutilainen M, Toivola DM. Colonocyte keratin 7 is expressed de novo in inflammatory bowel diseases and associated with pathological changes and drug-resistance. Sci Rep 2022;12:22213. [PMID: 36564440 DOI: 10.1038/s41598-022-26603-2] [Reference Citation Analysis]
3 Kruchinina MV, Svetlova IO, Osipenko MF, Abaltusova NV, Gromov AA, Shashkov MV, Sokolova AS, Yakovina IN, Borisova AV. Fatty Acids of Erythrocyte Membranes and Blood Serum in Differential Diagnosis of Inflammatory Bowel Diseases. Rossijskij žurnal gastroènterologii, gepatologii, koloproktologii 2022;32:50-67. [DOI: 10.22416/1382-4376-2022-32-4-50-67] [Reference Citation Analysis]
4 Hirayama H, Morita Y, Imai T, Takahashi K, Yoshida A, Bamba S, Inatomi O, Andoh A. Ustekinumab trough levels predicting laboratory and endoscopic remission in patients with Crohn's disease. BMC Gastroenterol 2022;22:195. [PMID: 35448957 DOI: 10.1186/s12876-022-02271-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Nijakowski K, Rutkowski R, Eder P, Korybalska K, Witowski J, Surdacka A. Changes in Salivary Parameters of Oral Immunity after Biologic Therapy for Inflammatory Bowel Disease. Life (Basel) 2021;11:1409. [PMID: 34947940 DOI: 10.3390/life11121409] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
6 Wagatsuma K, Yokoyama Y, Nakase H. Role of Biomarkers in the Diagnosis and Treatment of Inflammatory Bowel Disease. Life (Basel) 2021;11:1375. [PMID: 34947906 DOI: 10.3390/life11121375] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
7 Corsi F, Sorrentino L, Albasini S, Colombo F, Cigognini M, Massari A, Morasso C, Mazzucchelli S, Piccotti F, Ardizzone S, Sampietro GM, Truffi M. Circulating Fibroblast Activation Protein as Potential Biomarker in Patients With Inflammatory Bowel Disease. Front Med (Lausanne) 2021;8:725726. [PMID: 34621763 DOI: 10.3389/fmed.2021.725726] [Cited by in F6Publishing: 1] [Reference Citation Analysis]